Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-049513

Co-Chief Executive Officer sold 21,490 shares at $3.47 ($74,482)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2025-03-31 Sale −21,490 $3.47 $74,482 3,355,280 D
Open-market sales · 21,490 sh · avg $3.47 · $74,482
Loading xslF345X05/ownership.xml…